Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Cisplatin in Metastatic or Locally Advanced Penile Carcinoma
NCT00066391Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jun 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, open-label, single-arm trial of irinotecan and cisplatin in penile carcinoma, sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Objective Response Rate. Started Jun 2003; status: completed.
02
Drugs
irinotecancisplatin
03
Conditions
penile carcinoma
Beyond the preview
Go deeper on NCT00066391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066391.